Item 8.01. Other Events
As previously disclosed, on July 5, 2021, CF Acquisition Corp. V, a Delaware
corporation ("CF V") entered into an Agreement and Plan of Merger (as amended,
amended and restated, supplemented or otherwise modified from time to time, the
"Merger Agreement") with Satellogic Inc. ("PubCo"), Nettar Group Inc., (the
"Company") and certain other parties thereto. Pursuant to the Merger Agreement,
among other things, CF V and the Company will become direct, wholly owned
subsidiaries of PubCo. The transactions contemplated by the Merger Agreement are
referred to as the "Business Combination".
Columbia Loan Extension
On December 23, 2021, the Company entered into Amendment No. 2 to Loan and
Security Agreement (the "Amendment") which amends the Loan and Security
Agreement, dated as of March 8, 2021 (the "Columbia Loan Agreement"), by and
between the Company and Columbia River Investment Limited (the "Columbia
River"). The Amendment, among other things, (i) extends the date on which the
Company is required to pay all amounts due under the Columbia Loan Agreement
from December 31, 2021 (if the Business Combination closes on or prior to
December 31, 2021) to January 15, 2022 (if the Business Combination closes on or
prior to December 31, 2021 and the aggregate redemptions by the stockholders of
CF V exceed 50% of the amount in the CF V's trust account), or a later date if
mutually agreed to by the parties, (ii) extends the Perfection Date (as defined
in the Columbia Loan Agreement) to the earlier of (a) January 15, 2022 and
(b) the date the Company perfects the security interest on any collateral under
its other indebtedness, and (iii) makes certain other conforming amendments.
The description of the Amendment contained herein is not intended to be complete
and is qualified in its entirety by reference to the full text of the Amendment,
which is attached hereto as Exhibit 99.1 and is incorporated herein by
reference.
Promissory Note
On December 23, 2021, the Company and Cantor Fitzgerald Securities, a New York
general partnership ("CF Securities), entered into a Secured Promissory Note (as
amended, amended and restated, supplemented or otherwise modified from time to
time, the "Note") pursuant to which, CF Securities agreed to lend to the Company
(i) $7,500,000 (the "Initial Loan") and (ii) at the option of the Company, on or
before June 30, 2022, up to an additional $7,500,000 if certain conditions are
met including the Business Combination shall have been consummated, the
Permitted Equity Issuance (defined below) shall not have been consummated, and
Columbia River has agreed to certain amendments to the Columbia Loan Agreement
including a further extension of the maturity date thereunder by at least an
additional six months (the "Additional Loan" and together with the Initial Loan,
the "Loans").
The Loans will bear interest at a rate of 7.00% per annum provided that in the
event that the Loans are paid in full simultaneously with the closing of the
Business Combination with the proceeds of an equity issuance of at least
$100 million (as described in the Note) that is consummated on or prior to the
closing of the Business Combination ("Permitted Equity Issuance"), the Loans
shall bear interest at a rate of 5.00% per annum. Interest is payable quarterly
commencing on March 31, 2022.
The Note matures on the earlier of (i) December 23, 2022, (ii) the maturity date
under the Columbia Loan Agreement, as it may be extended and (iii) the closing
of the Business Combination, if the Permitted Equity Issuance is consummated on
or prior thereto. The Company is required to repay all or a portion of the Note
from the cash proceeds of any Permitted Equity Issuance or any other issuance of
any equity interests in the Company as set forth in the Note (the "Mandatory
Repayment"). The Company may prepay at any time upon notice all or any portion
of the Note (a "Voluntary Prepayment"). In the event of a Mandatory Repayment or
Voluntary Prepayment, the Company will be required to pay Lender a make-whole
premium equal to the aggregate interest payments that would be due with respect
to any repaid amounts through December 23, 2022 as if no such repayment had
occurred at a rate of 7.00% per annum with respect to any Voluntary Prepayments
and 5.00% per annum with respect to any Mandatory Repayment in connection with a
Permitted Equity Issuance that is consummated on or prior to the closing of the
Business Combination (or following the closing of the Business Combination,
subject to a binding commitment in respect thereof received prior to such
closing).
--------------------------------------------------------------------------------
As a condition to the Initial Loan, PubCo and the Company agreed that all
conditions to the closing of the Business Combination have been satisfied or
waived, including the condition that requires that the Available Cash (as
defined in the Merger Agreement) be no less than the Minimum Cash Amount (as
defined in the Merger Agreement), but excluding the SPAC Stockholders' Approval
(as defined in the Merger Agreement). PubCo and the Company have also agreed to
consummate the Merger Agreement within one day of CF V having obtained the
approval of the Business Combination by its stockholders.
The Note includes customary representations, warranties and events of default.
The Note also includes specified affirmative and negative covenants including an
obligation to provide the Lender quarterly and annual financial statements
within a certain period of time and limitation on debt incurrences, liens,
restricted payments, dispositions and investments. The Note is secured by a
security interest in certain assets of the Company and its subsidiaries. Upon
the earlier of (a) the date of the closing of the Business Combination and
(b) the date the Company's presently outstanding convertible notes are paid and
fully terminated, the Note will be secured by substantially all of the assets
and equity interests of the Company and its subsidiaries.
The description of the Note contained herein is not intended to be complete and
is qualified in its entirety by reference to the full text of the Note, which is
attached hereto as Exhibit 99.2 and is incorporated herein by reference.
Important Information and Where to Find It
This Current Report on Form 8-K relates to a proposed transaction between CF V,
PubCo and the Company. In connection with the transaction described herein, CF V
and/or PubCo has filed materials with the SEC, including an effective
registration statement on Form F-4, which includes a proxy statement/prospectus.
CF V and/or PubCo may also file other documents regarding the proposed
transaction with the SEC. Before making any voting or investment decision,
investors and security holders of CF V are urged to read the F-4 Registration
Statement, the proxy statement/prospectus and all other relevant documents filed
or that will be filed with the SEC in connection with the proposed transaction
as they become available because they will contain important information about
the proposed transaction.
Investors and security holders are able to obtain free copies of the proxy
statement/prospectus and all other relevant documents filed or that will be
filed with the SEC by CF V through the website maintained by the SEC at
www.sec.gov or by directing a request to CF V to 110 East 59th Street, New York,
NY 10022 or via email at CFV@cantor.com.
Participants in the Solicitation
CF V, PubCo and the Company and their respective directors and executive
officers may be deemed to be participants in the solicitation of proxies from CF
V's stockholders in connection with the proposed transaction. Information about
CF V's directors and executive officers and their ownership of CF V's securities
is set forth in CF V's filings with the SEC. Additional information regarding
the interests of those persons and other persons who may be deemed participants
in the proposed transaction may be obtained by reading the proxy
statement/prospectus regarding the proposed transaction when it becomes
available. You may obtain free copies of these documents as described in the
section entitled "Important Information and Where to Find It" above.
Non-Solicitation
This Current Report on Form 8-K is not a proxy statement or solicitation of a
proxy, consent or authorization with respect to any securities or in respect of
the potential transaction and shall not constitute an offer to sell or a
solicitation of an offer to buy the securities of CF V, PubCo or the Company,
nor shall there be any sale of any such securities in any state or jurisdiction
in which such offer, solicitation, or sale would be unlawful prior to
registration or qualification under the securities laws of such state or
jurisdiction. No offer of securities shall be made except by means of a
prospectus meeting the requirements of the Securities Act.
--------------------------------------------------------------------------------
Forward-Looking Statements
This Current Report on Form 8-K contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended, including
statements regarding the proposed transaction between CF V, PubCo and the
Company. Such forward-looking statements include, but are not limited to,
statements regarding the closing of the transaction and CF V's, the Company's or
their respective management teams' expectations, hopes, beliefs, intentions or
strategies regarding the future. The words "anticipate", "believe", "continue",
"could", "estimate", "expect", "intends", "may", "might", "plan", "possible",
"potential", "predict", "project", "should", "would" and similar expressions may
identify forward-looking statements, but the absence of these words does not
mean that a statement is not forward-looking. These statements are based on
various assumptions. Actual events and circumstances are difficult or impossible
to predict and will differ from assumptions. Many actual events and
circumstances are beyond the control of CF V, PubCo and the Company. Many
factors could cause actual future events to differ materially from the
forward-looking statements in this Current Report on Form 8-K, including but not
limited to: (i) the risk that the transaction may not be completed in a timely
manner or at all, which may adversely affect the price of CF V's securities,
(ii) the failure to satisfy the conditions to the consummation of the
transaction, including the adoption of the Merger Agreement by CF V's
stockholders, the satisfaction of the minimum trust account amount following any
redemptions by CF V's public stockholders and the receipt of certain
governmental and regulatory approvals, (iii) the occurrence of any event, change
or other circumstance that could give rise to the termination of the Merger
Agreement, (iv) the inability to complete the PIPE Investment, (v) the effect of
the announcement or pendency of the transaction on the Company's business
relationships, operating results and business generally, (vi) risks that the
transaction disrupts current plans and operations of the Company, (vii) changes
in the competitive and highly regulated industries in which the Company
operates, variations in operating performance across competitors and changes in
laws and regulations affecting the Company's business, (viii) the ability to
implement business plans, forecasts and other expectations after the completion
of the transaction, and identify and realize additional opportunities, (ix) the
risk of downturns in the commercial launch services, satellite and spacecraft
industry, (x) the outcome of any legal proceedings that may be instituted
against the Company, PubCo or CF V related to the Merger Agreement or the
transaction, (xi) volatility in the price of CF V's or any successor entity's
securities due to a variety of factors, including changes in the competitive and
highly regulated industries in which the Company operates or plans to operate,
variations in performance across competitors, changes in laws and regulations
affecting the Company's business and changes in the combined capital structure,
(xii) costs related to the transaction and the failure to realize anticipated
benefits of the transaction or to realize estimated pro forma results and
underlying assumptions, including with respect to estimated stockholder
redemptions, (xiii) the risk that the Company and its current and future
collaborators are unable to successfully develop and commercialize the Company's
products or services, or experience significant delays in doing so, (xiv) the
risk that the Company may never achieve or sustain profitability, (xv) the risk
that the Company may need to raise additional capital to execute its business
plan, which many not be available on acceptable terms or at all, (xvi) the risk
that the post-combination company experiences difficulties in managing its
growth and expanding operations, (xvii) the risk that third-party suppliers and
manufacturers are not able to fully and timely meet their obligations,
(xviii) the risk of product liability or regulatory lawsuits or proceedings
relating to the Company's products and services, (xix) the risk that the Company
is unable to secure or protect its intellectual property and (xx) the risk that
the post-combination company's securities will not be approved for listing on
Nasdaq, NYSE or another stock exchange or if approved, maintain the listing. The
foregoing list of factors is not exhaustive. You should carefully consider the
foregoing factors and the other risks and uncertainties described in the "Risk
Factors" section of CF V's Registration Statement on Form S-1, the registration
statement on Form F-4 and proxy statement/prospectus discussed above and other
documents filed or to be filed by CF V, PubCo and/or or any successor entity of
the transaction from time to time with the SEC (including CF V's quarterly
filings). These filings identify and address other important risks and
uncertainties that could cause actual events and results to differ materially
from those contained in the forward-looking statements. Forward-looking
statements speak only as of the date they are made. Readers are cautioned not to
put undue reliance on forward-looking statements, and CF V, PubCo and the
Company assume no obligation and do not intend to update or revise these
forward-looking statements, whether as a result of new information, future
events, or otherwise. None of CF V, PubCo or the Company give any assurance that
any of CF V, PubCo or the Company will achieve its expectations.
. . .
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No. Description
99.1 Amendment No. 2 to Loan and Security Agreement dated December 23,
2021.
99.2 Promissory Note dated December 23, 2021.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses